Histone Acetylation-Mediated Regulation of the Hippo Pathway

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Basu, Dipanjan ^a   Reyes Múgica, Miguel ^a   Rebbaa, Abdelhadi ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ALPHA ACTININ 2; BELINOSTAT; CELL PROTEIN; CISPLATIN; CONNECTIVE TISSUE GROWTH FACTOR; CYTOKINE; DOXORUBICIN; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 23; FLUOROURACIL; GLYCOGEN SYNTHASE KINASE 3BETA; GROWTH FACTOR; HISTONE; HISTONE DEACETYLASE INHIBITOR; LUCIFERASE; NERVE CELL ADHESION MOLECULE; PROTEIN KINASE B; PROTEIN TAZ; PYRVINIUM EMBONATE; SOMATOMEDIN C; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR TWIST; TRANSFORMING GROWTH FACTOR BETA2; TRICHOSTATIN A; UNCLASSIFIED DRUG; UVOMORULIN; WNT10A PROTEIN; WNT4 PROTEIN; WNT7B PROTEIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CARCINOGENESIS; CELL JUNCTION; CELL MIGRATION; CELL NUCLEUS; CHROMATIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA DAMAGE; DRUG TARGETING; ENZYME ACTIVATION; ENZYME REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; HIPPO PATHWAY; HISTONE ACETYLATION; HUMAN; HUMAN CELL; METABOLIC REGULATION; PROTEIN DEGRADATION; PROTEIN SECRETION; PROTEIN STABILITY; REPORTER GENE; SIGNAL TRANSDUCTION; TUMOR GROWTH;

ACETYLATION; ANTINEOPLASTIC AGENTS; CELL MOVEMENT; CHROMATIN ASSEMBLY AND DISASSEMBLY; CYTOKINES; DNA DAMAGE; DRUG RESISTANCE, NEOPLASM; GLYCOGEN SYNTHASE KINASE 3; HEK293 CELLS; HISTONE DEACETYLASE INHIBITORS; HISTONES; HUMANS; HYDROXAMIC ACIDS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MCF-7 CELLS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STABILITY; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; SULFONAMIDES; TRANSCRIPTION FACTORS;

EID: 84877093008     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062478     Document Type: Article

References (56)

1. Harvey KF, Hariharan IK, (2012) The hippo pathway. Cold Spring Harb Perspect Biol 4: a011288.
2. Grusche FA, Richardson HE, Harvey KF, (2010) Upstream regulation of the hippo size control pathway. Curr Biol 20: R574-582.
3. Halder G, Johnson RL, (2011) Hippo signaling: growth control and beyond. Development 138: 9-22.
4. Zhao B, Tumaneng K, Guan KL, (2011) The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nat Cell Biol 13: 877-883.
5. Oh H, Irvine KD, (2010) Yorkie: the final destination of Hippo signaling. Trends Cell Biol 20: 410-417.
6. Xu T, Wang W, Zhang S, Stewart RA, Yu W, (1995) Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase. Development 121: 1053-1063.
7. Harvey KF, Pfleger CM, Hariharan IK, (2003) The Drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis. Cell 114: 457-467.
8. Udan RS, Kango-Singh M, Nolo R, Tao C, Halder G, (2003) Hippo promotes proliferation arrest and apoptosis in the Salvador/Warts pathway. Nat Cell Biol 5: 914-920.
9. Wu S, Huang J, Dong J, Pan D, (2003) hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts. Cell 114: 445-456.
10. Sudol M, (2010) Newcomers to the WW Domain-Mediated Network of the Hippo Tumor Suppressor Pathway. Genes Cancer 1: 1115-1118.
11. Zhao B, Wei X, Li W, Udan RS, Yang Q, et al. (2007) Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev 21: 2747-2761.
12. Hao Y, Chun A, Cheung K, Rashidi B, Yang X, (2008) Tumor suppressor LATS1 is a negative regulator of oncogene YAP. J Biol Chem 283: 5496-5509.
13. Kanai F, Marignani PA, Sarbassova D, Yagi R, Hall RA, et al. (2000) TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins. EMBO J 19: 6778-6791.
14. Lei QY, Zhang H, Zhao B, Zha ZY, Bai F, et al. (2008) TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway. Mol Cell Biol 28: 2426-2436.
15. Oh H, Irvine KD, (2008) In vivo regulation of Yorkie phosphorylation and localization. Development 135: 1081-1088.
16. Huang W, Lv X, Liu C, Zha Z, Zhang H, et al. (2012) The N-terminal phosphodegron targets TAZ/WWTR1 protein for SCFbeta-TrCP-dependent degradation in response to phosphatidylinositol 3-kinase inhibition. J Biol Chem 287: 26245-26253.
17. Azzolin L, Zanconato F, Bresolin S, Forcato M, Basso G, et al. (2012) Role of TAZ as mediator of Wnt signaling. Cell 151: 1443-1456.
18. Chen HJ, Wang CM, Wang TW, Liaw GJ, Hsu TH, et al. (2011) The Hippo pathway controls polar cell fate through Notch signaling during Drosophila oogenesis. Dev Biol 357: 370-379.
19. Mardin BR, Lange C, Baxter JE, Hardy T, Scholz SR, et al. (2010) Components of the Hippo pathway cooperate with Nek2 kinase to regulate centrosome disjunction. Nat Cell Biol 12: 1166-1176.
20. Lian I, Kim J, Okazawa H, Zhao J, Zhao B, et al. (2010) The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation. Genes Dev 24: 1106-1118.
21. Harvey K, Tapon N, (2007) The Salvador-Warts-Hippo pathway- an emerging tumour-suppressor network. Nat Rev Cancer 7: 182-191.
22. St John MA, Tao W, Fei X, Fukumoto R, Carcangiu ML, et al. (1999) Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunction. Nat Genet 21: 182-186.
23. Zhou Z, Hao Y, Liu N, Raptis L, Tsao MS, et al. (2011) TAZ is a novel oncogene in non-small cell lung cancer. Oncogene 30: 2181-2186.
24. de Cristofaro T, Di Palma T, Ferraro A, Corrado A, Lucci V, et al. (2011) TAZ/WWTR1 is overexpressed in papillary thyroid carcinoma. Eur J Cancer 47: 926-933.
25. Konsavage WM Jr, Kyler SL, Rennoll SA, Jin G, Yochum GS, (2012) Wnt/beta-catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells. J Biol Chem 287: 11730-11739.
26. Wang Y, Dong Q, Zhang Q, Li Z, Wang E, et al. (2010) Overexpression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer. Cancer Sci 101: 1279-1285.
27. Zender L, Spector MS, Xue W, Flemming P, Cordon-Cardo C, et al. (2006) Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell 125: 1253-1267.
28. Varelas X, Miller BW, Sopko R, Song S, Gregorieff A, et al. (2010) The Hippo pathway regulates Wnt/beta-catenin signaling. Dev Cell 18: 579-591.
29. Alarcon C, Zaromytidou AI, Xi Q, Gao S, Yu J, et al. (2009) Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways. Cell 139: 757-769.
30. Varelas X, Samavarchi-Tehrani P, Narimatsu M, Weiss A, Cockburn K, et al. (2010) The Crumbs complex couples cell density sensing to Hippo-dependent control of the TGF-beta-SMAD pathway. Dev Cell 19: 831-844.
31. Liu Y, Xin Y, Ye F, Wang W, Lu Q, et al. (2010) Taz-tead1 links cell-cell contact to zeb1 expression, proliferation, and dedifferentiation in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 51: 3372-3378.
32. Zhang J, Smolen GA, Haber DA, (2008) Negative regulation of YAP by LATS1 underscores evolutionary conservation of the Drosophila Hippo pathway. Cancer Res 68: 2789-2794.
33. Cordenonsi M, Zanconato F, Azzolin L, Forcato M, Rosato A, et al. (2011) The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells. Cell 147: 759-772.
34. Grzeschik NA, Parsons LM, Allott ML, Harvey KF, Richardson HE, (2010) Lgl, aPKC, and Crumbs regulate the Salvador/Warts/Hippo pathway through two distinct mechanisms. Curr Biol 20: 573-581.
35. Robinson BS, Huang J, Hong Y, Moberg KH, (2010) Crumbs regulates Salvador/Warts/Hippo signaling in Drosophila via the FERM-domain protein Expanded. Curr Biol 20: 582-590.
36. Yu FX, Zhao B, Panupinthu N, Jewell JL, Lian I, et al. (2012) Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling. Cell 150: 780-791.
37. Miller E, Yang J, Deran M, Wu C, Su AI, et al. (2012) Identification of Serum-Derived Sphingosine-1-Phosphate as a Small Molecule Regulator of YAP. Chem Biol 19: 955-962.
38. Rebbaa A, Chou PM, Mirkin BL, (2001) Factors secreted by human neuroblastoma mediated doxorubicin resistance by activating STAT3 and inhibiting apoptosis. Mol Med 7: 393-400.
39. Mirkin BL, Clark S, Zheng X, Chu F, White BD, et al. (2005) Identification of midkine as a mediator for intercellular transfer of drug resistance. Oncogene 24: 4965-4974.
40. Lai D, Ho KC, Hao Y, Yang X, (2011) Taxol resistance in breast cancer cells is mediated by the hippo pathway component TAZ and its downstream transcriptional targets Cyr61 and CTGF. Cancer Res 71: 2728-2738.
41. Salic A, Lee E, Mayer L, Kirschner MW, (2000) Control of beta-catenin stability: reconstitution of the cytoplasmic steps of the wnt pathway in Xenopus egg extracts. Mol Cell 5: 523-532.
42. Lyons JP, Mueller UW, Ji H, Everett C, Fang X, et al. (2004) Wnt-4 activates the canonical beta-catenin-mediated Wnt pathway and binds Frizzled-6 CRD: functional implications of Wnt/beta-catenin activity in kidney epithelial cells. Exp Cell Res 298: 369-387.
43. Zhang C, Zhang F, Tsan R, Fidler IJ, (2009) Transforming growth factor-beta2 is a molecular determinant for site-specific melanoma metastasis in the brain. Cancer Res 69: 828-835.
44. Zhao L, Jiang S, Hantash BM, (2010) Transforming growth factor beta1 induces osteogenic differentiation of murine bone marrow stromal cells. Tissue Eng Part A 16: 725-733.
45. Cho HH, Shin KK, Kim YJ, Song JS, Kim JM, et al. (2010) NF-kappaB activation stimulates osteogenic differentiation of mesenchymal stem cells derived from human adipose tissue by increasing TAZ expression. J Cell Physiol 223: 168-177.
46. Konsavage WM, Jr., Yochum GS (2012) Intersection of Hippo/YAP and Wnt/beta-catenin signaling pathways. Acta Biochim Biophys Sin (Shanghai).
47. Thorne CA, Hanson AJ, Schneider J, Tahinci E, Orton D, et al. (2010) Small-molecule inhibition of Wnt signaling through activation of casein kinase 1alpha. Nat Chem Biol 6: 829-836.
48. McCaffrey LM, Macara IG, (2011) Epithelial organization, cell polarity and tumorigenesis. Trends Cell Biol 21: 727-735.
49. Martin-Belmonte F, Perez-Moreno M, (2012) Epithelial cell polarity, stem cells and cancer. Nat Rev Cancer 12: 23-38.
50. Prince HM, Bishton MJ, Harrison SJ, (2009) Clinical studies of histone deacetylase inhibitors. Clin Cancer Res 15: 3958-3969.
51. Avruch J, Zhou D, Bardeesy N, (2012) YAP oncogene overexpression supercharges colon cancer proliferation. Cell Cycle 11: 1090-1096.
52. Pazolli E, Alspach E, Milczarek A, Prior J, Piwnica-Worms D, et al. (2012) Chromatin remodeling underlies the senescence-associated secretory phenotype of tumor stromal fibroblasts that supports cancer progression. Cancer Res 72: 2251-2261.
53. Basu D, Reyes-Mugica M, Rebbaa A, (2012) Role of the Beta catenin destruction complex in mediating chemotherapy-induced senescence-associated secretory phenotype. PLoS One 7: e52188.
54. Chu F, Chou P, Mirkin BL, Mousa SA, Rebbaa A, (2008) Cellular conditioning with trichostatin A enhances the anti-stress response through up-regulation of HDAC4 and down-regulation of the IGF/Akt pathway. Aging Cell 7: 516-525.
55. Mousa SA, Sudha T, Dyskin E, Dier U, Gallati C, et al. (2010) Stress resistant human embryonic stem cells as a potential source for the identification of novel cancer stem cell markers. Cancer Lett 289: 208-216.
56. Li XJ, Peng LX, Shao JY, Lu WH, Zhang JX, et al. (2012) As an independent unfavorable prognostic factor, IL-8 promotes metastasis of nasopharyngeal carcinoma through induction of epithelial-mesenchymal transition and activation of AKT signaling. Carcinogenesis 33: 1302-1309.